Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients

Pediatric Infectious Disease Journal

Volumn 23, Issue 10, 2004, Pages 963-965

  De Sio, Luigi ^a   Jenkner, Alessandro ^a   Milano, Giuseppe Maria ^a   Ilari, Ilaria ^a   Fidani, Paola ^a   Castellano, Aurora ^a   Gareri, Roberta ^a   Donfrancesco, Alberto ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Antibiotic lock technique; Central venous catheter; Gram positive bacteremia; Pediatric cancer patients; Urokinase; Vancomycin

Indexed keywords

AMIKACIN; CEPHALOSPORIN; PIPERACILLIN; UROKINASE; VANCOMYCIN; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT;

ADOLESCENT; ANTIBIOTIC LOCK; ARTICLE; BACTEREMIA; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CORYNEBACTERIUM; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; INFANT; MALE; MICROCOCCUS; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HOMINIS; TREATMENT OUTCOME; CENTRAL VENOUS CATHETERIZATION; CLINICAL TRIAL; EQUIPMENT; INDWELLING CATHETER; MICROBIOLOGY; NEOPLASM; PRESCHOOL CHILD;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTICOAGULANTS; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; EQUIPMENT CONTAMINATION; FEMALE; HUMANS; INFANT; MALE; NEOPLASMS; URINARY PLASMINOGEN ACTIVATOR; VANCOMYCIN;

EID: 16544378239     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000141740.82420.e6     Document Type: Article

References (12)

1. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32: 1249-1272.
2. Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. J Parenter Enteral Nutr. 1988;12:185-189.
3. Krzywda EA, Andris DA, Edmiston CE Jr, Quebbeman EJ. Treatment of Hickman catheter sepsis using antibiotic lock technique. Infect Control Hosp Epidemiol. 1995;16:596-598.
4. Gonzalez-Barca E, Fernandez-Sevilla A, Carratala J, Granena A, Gudiol F. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. Eur J Clin Microbiol Infect Dis. 1996; 15:291-296.
5. Quie PG, Belani KK. Coagulase-negative staphylococci adherence and persistence. J Infect Dis. 1987;156:543-547.
6. Wiener E, McGuire P, Stolare CJH, et al. The CCSG prospective study of venous access devices: an analysis of insertions and causes for removal. J Pediatr Surg. 1992;27:155-164.
7. Carratala J. The antibiotic-lock technique for therapy of 'highly needed' infected catheters. Clin Microbiol Infect. 2002;8:282-289.
8. Rao JS, O'Meara A, Harvey T, Breatnach F. A new approach to the management of Broviac catheter infection. J Hosp Infect. 1992;22:109-116.
9. Webster A, Russell SJ, Souhami RL, Richards JD, Goldstone AH, Gruneberg RN. Use of teicoplanin for Hickman catheter associated staphylococcal infection in immunosuppressed patients. J Hosp Infect. 1987;10:77-82.
10. Wood MJ. Comparative safety of teicoplanin and vancomycin. J Chemother. 2000;12:21-25.
11. Anthony TU, Rubin LG. Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports). Antimicrob Agents Chemother. 1999;43:2074-2076.
12. Johnson DC, Johnson FL, Goldman S. Preliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patients. Pediatr Infect Dis J. 1994;13:930-931.